These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C; Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361 [TBL] [Abstract][Full Text] [Related]
9. Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial. Molina JM; Grund B; Gordin F; Williams I; Schechter M; Losso M; Law M; Ekong E; Mwelase N; Skoutelis A; Wiselka MJ; Vandekerckhove L; Benfield T; Munroe D; Lundgren JD; Neaton JD; Lancet HIV; 2018 Apr; 5(4):e172-e180. PubMed ID: 29352723 [TBL] [Abstract][Full Text] [Related]
10. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa. Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S; HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667 [TBL] [Abstract][Full Text] [Related]
11. Elite and viremic HIV-1 controllers in West Africa. N'takpé JB; Gabillard D; Moh R; Gardiennet E; Toni TD; Kouame GM; Badje A; Emieme A; Karcher S; Le Carrou J; Ménan H; Danel C; Eholie SP; Rouzioux C; Anglaret X; Lambotte O AIDS; 2022 Jan; 36(1):29-38. PubMed ID: 34524145 [TBL] [Abstract][Full Text] [Related]
12. ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial. Sereti I; Gulick RM; Krishnan S; Migueles SA; Palfreeman A; Touzeau-Römer V; Belloso WH; Emery S; Law MG; J Acquir Immune Defic Syndr; 2019 Aug; 81(4):456-462. PubMed ID: 31241541 [TBL] [Abstract][Full Text] [Related]
13. Ten-year attrition and antiretroviral therapy response among HIV-positive adults: a sex-based cohort analysis from eight West African countries. Tiendrebeogo T; Messou E; Arikawa S; Ekouevi DK; Tanon A; Kwaghe V; Balestre E; Zannou MD; Poda A; Dabis F; Jaquet A; Minga A; Becquet R; J Int AIDS Soc; 2021 May; 24(5):e25723. PubMed ID: 34021714 [TBL] [Abstract][Full Text] [Related]
14. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. ; Lundgren JD; Babiker AG; Gordin F; Emery S; Grund B; Sharma S; Avihingsanon A; Cooper DA; Fätkenheuer G; Llibre JM; Molina JM; Munderi P; Schechter M; Wood R; Klingman KL; Collins S; Lane HC; Phillips AN; Neaton JD N Engl J Med; 2015 Aug; 373(9):795-807. PubMed ID: 26192873 [TBL] [Abstract][Full Text] [Related]
15. Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa. Balestre E; Eholié SP; Lokossue A; Sow PS; Charurat M; Minga A; Drabo J; Dabis F; Ekouevi DK; Thiébaut R; AIDS; 2012 May; 26(8):951-7. PubMed ID: 22382142 [TBL] [Abstract][Full Text] [Related]
16. The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection. Sharma S; Schlusser KE; de la Torre P; Tambussi G; Draenert R; Pinto AN; Metcalf JA; Neaton JD; Laeyendecker O; AIDS; 2019 Jul; 33(8):1335-1344. PubMed ID: 31157663 [TBL] [Abstract][Full Text] [Related]
17. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M; Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120 [TBL] [Abstract][Full Text] [Related]
18. High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire. Ghehi C; Gabillard D; Moh R; Badje A; Kouamé GM; Oouttara E; Ahibo H; N'Takpé JB; Lecarrou J; Eholié SP; Anglaret X; Danel C PLoS One; 2017; 12(6):e0177440. PubMed ID: 28582393 [TBL] [Abstract][Full Text] [Related]
19. Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean. Carriquiry G; Fink V; Koethe JR; Giganti MJ; Jayathilake K; Blevins M; Cahn P; Grinsztejn B; Wolff M; Pape JW; Padgett D; Madero JS; Gotuzzo E; McGowan CC; Shepherd BE J Int AIDS Soc; 2015; 18(1):20016. PubMed ID: 26165322 [TBL] [Abstract][Full Text] [Related]
20. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa. Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]